Codiak Biosciences, Inc.
CDAKQ
Revenue
522.00k
▼-12.62M▼-96.03%
3 Months ChangeAssets
134.40M
▲1.69M▲1.27%
3 Months ChangeLiabilities
95.47M
▲7.16M▲8.10%
3 Months ChangeFree Cash Flow
-21.03M
▲130.00k▲0.6143%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2023-03-29
Form 8-K
ID: 0001193125-23-082411
2023-03-27
Form 8-K
ID: 0001193125-23-079964
2022-11-03
Form 10-Q
ID: 0000950170-22-021879
2022-11-03
Form 8-K
ID: 0001193125-22-276888
2022-09-14
Form 8-K
ID: 0001193125-22-243959
2022-08-30
Form 8-K
ID: 0001193125-22-233603
2022-08-04
Form 10-Q
ID: 0000950170-22-014755
2022-08-04
Form 8-K
ID: 0001193125-22-212503
2022-06-30
Form 8-K
ID: 0001193125-22-185512
2022-06-29
Form 8-K
ID: 0001193125-22-184431